Expression of factor VIII by murine liver sinusoidal endothelial cells
- PMID: 10391893
- DOI: 10.1074/jbc.274.28.19587
Expression of factor VIII by murine liver sinusoidal endothelial cells
Abstract
Factor VIII (fVIII) is the procoagulant plasma glycoprotein that is missing or decreased in hemophilia A. The cellular origin of fVIII synthesis is controversial. Liver transplantation cures hemophilia A, demonstrating that the liver is a major site of fVIII synthesis. We detected fVIII mRNA in purified populations of murine liver sinusoidal endothelial cells (LSECs) and hepatocytes, but not Kupffer cells. LSECs and hepatocytes contained comparable numbers of fVIII mRNA (40 and 70 transcripts per cell, respectively) by quantitative competitive reverse transcriptase-polymerase chain reaction analysis. There was not detectable mRNA for factor IX, a hepatocyte marker, in the LSEC preparation, nor was there detectable mRNA for von Willebrand factor, an endothelial cell marker, in the hepatocyte preparation. This excludes the possibility that detectable fVIII mRNA is due to cross-contamination in the hepatocyte or LSEC preparations. Primary cultures of LSECs were established in which fVIII mRNA levels were indistinguishable from purified LSECs. LSECs secreted active fVIII into the culture medium. This finding represents the first demonstration of homologous expression of fVIII mRNA and protein in cell culture and should facilitate studies of fVIII gene regulation. Additionally, LSECs potentially are _targets for a fVIII transgene during gene therapy of hemophilia A.
Similar articles
-
Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice.PLoS One. 2013 Oct 22;8(10):e77255. doi: 10.1371/journal.pone.0077255. eCollection 2013. PLoS One. 2013. PMID: 24167566 Free PMC article. Clinical Trial.
-
Transplantation of endothelial cells corrects the phenotype in hemophilia A mice.J Thromb Haemost. 2005 Sep;3(9):2022-31. doi: 10.1111/j.1538-7836.2005.01508.x. J Thromb Haemost. 2005. PMID: 16102109
-
Tissue distribution of factor VIII gene expression in vivo--a closer look.Thromb Haemost. 2001 Sep;86(3):855-61. Thromb Haemost. 2001. PMID: 11583319
-
Platelet and endothelial expression of clotting factors for the treatment of hemophilia.Thromb Res. 2012 May;129 Suppl 2(Suppl 2):S46-8. doi: 10.1016/j.thromres.2012.02.031. Epub 2012 Mar 14. Thromb Res. 2012. PMID: 22421106 Free PMC article. Review.
-
Molecular basis of haemophilia A.Haemophilia. 2004 Oct;10 Suppl 4:133-9. doi: 10.1111/j.1365-2516.2004.01005.x. Haemophilia. 2004. PMID: 15479386 Review.
Cited by
-
Ultrasound-mediated gene delivery specifically _targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice.Mol Ther. 2024 Apr 3;32(4):969-981. doi: 10.1016/j.ymthe.2024.02.010. Epub 2024 Feb 9. Mol Ther. 2024. PMID: 38341614
-
Mesenchymal stem cells contribute to endogenous FVIII:c production.J Cell Physiol. 2013 May;228(5):1010-6. doi: 10.1002/jcp.24247. J Cell Physiol. 2013. PMID: 23042590 Free PMC article.
-
The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.Blood. 2010 Jun 3;115(22):4580-7. doi: 10.1182/blood-2009-09-244327. Epub 2010 Mar 24. Blood. 2010. PMID: 20335223 Free PMC article.
-
The role of microRNAs in defining LSECs cellular identity and in regulating F8 gene expression.Front Genet. 2024 Feb 19;15:1302685. doi: 10.3389/fgene.2024.1302685. eCollection 2024. Front Genet. 2024. PMID: 38440189 Free PMC article.
-
Factor VIII ectopically _targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.J Clin Invest. 2006 Jul;116(7):1974-82. doi: 10.1172/JCI28416. J Clin Invest. 2006. PMID: 16823491 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
